Introduction
The inositols are the nine isomeric forms of cyclohexanehexol, a group of small and chemically very stable polar molecules that have versatile properties (reviewed in Refs. 1, 2). Myo-inositol (MI) is the most abundant isomer and is an ubiquitous component of all eukaryotic cells. The central nervous system (CNS) is characterized with relatively high concentrations of MI as well as the means to synthesize it. MI serves not only as a precursor molecule for inositol lipid synthesis, but also as a physiologically important osmolyte (reviewed in Ref. 2) . Alteration in MI deposition may play role in the number of neuropathological conditions, where MI acts either as a physiologically important osmolyte or as a precursor molecule for phosphoinositide synthesis (reviewed in Ref. 2) .
Our previous experiments have revealed that an aqueous extract of the plant Aquilegia vulgaris (medicinal herb used in treatment of epilepsy and insomnia) contains compounds altering binding of ligands to the benzodiazepine and g-aminobuturic acid (GABA) binding sites of the GABA-A receptors. 3 We have identified two constituents of this extract: (1) MI and (2) Scyllo-inositol (SCI) is one of the inositol isomers and is present in human brain in quantities estimated to be from 5 to 12% that of MI. 2, 6 A specific epimerase in the rat and rabbit brains converts MI to SCI. 7, 8 The existence of a specific enzyme for its synthesis suggests that SCI is physiologically important. SCI inhibits aggregation of amyloid b peptide into high molecular weight oligomers in the brain and ameliorates several Alzheimer disease like-phenotypes. 9 In doing so SCI is more effective than epiinositol, whereas MI does not have any detectable effect. 9 In the present study we have inquired whether or not SCI possesses anticonvulsant properties on PTZ induced seizures. This has not been yet reported to the best of our knowledge. The present experimental design included MI treated group (to compare with SCI effects), and the additional mannitol (MAN) treated control group (sugar of the same molecular weight). Furthermore, more detailed behavioral analysis of convulsive seizures, compared to our initial MI study 4 has been performed.
Methods
All animal experiments were carried out at the I. Beritashvili Institute of Physiology and were performed in accordance with Seizures Myo-inositol Scyllo-inositol Pentylenetetrazol A B S T R A C T Myo-inositol (MI) and its isomers are used for the treatment of various neuropathological conditions. The purpose of the present research was to study anticonvulsant properties of MI and scyllo-inositol (SCI) on pentylenetetrazol (PTZ) induced seizures in rats. Half an hour after treatment with MI (30 mg/ kg) or SCI (5 mg/kg) seizures were induced in Wistar rats with PTZ (60 mg/kg). Control animals were treated either by normal saline or mannitol (control polyol of the same molecular weight, 30 mg/kg), given at the same time interval before PTZ injection, as MI/SCI groups. The anticonvulsant effects of MI/ SCI treatment were assessed by the latent period (the time from PTZ-injection to the onset of first seizures), and the duration and severity (score) of seizures. The mortality rate was also assessed. Both MI and SCI treatment significantly reduced the seizure score, seizure duration and increased the latent period. These data suggest for strong potential of MI and SCI as the agents of antiepileptic therapy.
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approved Institutional animal care guidelines. Adult Wistar rats weighing 140-170 g were used throughout this study. PTZ, MAN, MI and SCI (all from Sigma) were dissolved in normal saline before injection. Experiments were carried on four groups of animals. In all cases PTZ (60 mg/kg) was administered 30 min after primary injections of different compounds. In the first group primary injection was done by saline (SAL + PTZ group), in the second group by MAN (30 mg/kg), (MAN + PTZ group), in the third group by MI (30 mg/ kg), (MI + PTZ group) and in the fourth group by SCI (5 mg/kg) (SCI + PTZ group). All compounds were administered intraperitoneally.
The main criterion for determination of the administered doses of MI and SCI was that it should be in the range of 3-10% of existing concentrations of these compounds in the rat brain. 2 The used doses more precisely were selected according to the following: (i) in the pilot studies with 1, 2.5 and 5 mg/kg of SCI only 5 mg/kg demonstrated a trend of anticonvulsant effect; (ii) in the pilot studies of our previous work 4 the trend of anticonvulsant activity for MI was shown only for the dose starting from 20 mg/kg and the dose of 30 mg/kg MI prevented biochemical changes triggered by KA-induced SE 5 ; (iii) the dose of MAN is equivalent to the highest dose of inositol used in these experiments. Each animal was placed into an individual plastic cage for observation lasting 1 h. Mortality was estimated by the proportion of the death within 1 h and the time to onset of convulsive seizures, duration of seizures, and the seizure severity were determined for each animal. The convulsive seizures were scored according to a modified Racine scoring grade from 0 to 6: 0-no motor seizures; 1-freezing, staring, mouth or facial movements; 2-head nodding or isolated twitches, rigid posture; 3-tail extension, unilateralbilateral forelimb clonus; 4-rearing, in which the mice sit in an immobile state on their rear haunches with one or both forepaws extended; 5-clonic seizures, loss of posture, jumping and forepaws extended; 6-tonic seizures with hindlimb extension[see 10, 11] . Each animal was assigned the score of the most severe seizure observed.
Each group consisted of 10 animals. In each replication of the experiment all four groups were tested. There were five replications of the experiment. Thus, in total 200 animals were used in this study. The calculation of the number of experimental animals and the sample size was based on the data obtained from our previous study. 4 
Statistical analysis
The effect of tested compounds on the seizure grade was evaluated by Kruskal-Wallis test. Planned comparisons were made by Mann-Whitney test.
The mortality rate, latent period, and duration and severity of seizures were analyzed by one-way analysis of variances (one-way ANOVA). The data from animals which did not develop PTZ induced SE were excluded from the analysis of latent period. Planned comparisons between groups were made using t-tests. All statistical tests were two-tailed.
Results

PTZ induced seizure scores
The effect of experimental factor on the seizure score was statistically significant (H = 13.23, DF = 3, P = 0.0043). MI and SCI significantly reduced the seizure score compared to saline control (MI + PTZ vs SAL + PTZ, W = 2939.5, P = 0.0043; SCI + PTZ vs SAL + PTZ, W = 2935.0, P = 0.0048). Both isomers of inositol also significantly decreased the severity of seizures as compared to MAN + PTZ group (MI + PTZ vs MAN + PTZ, W = 2503.5, P = 0.046; SCI + PTZ vs MAN + PTZ, W = 2540.0, P = 0.023) (see Fig. 1A ).
Latent period
The latency of seizure onset significantly changed under experimental conditions (see Table 1 ). MI treatment significantly delayed the onset of seizures compared to SAL + PTZ group (t = 2.26, P = 0.027) and MAN + PTZ group (t = 3.45, P = 0.001). The latent period was increased in SCI + PTZ group as compared to MAN + PTZ group (t = 2.03, P = 0.045). No other differences were statistically significant (see also Fig. 1B ).
Seizure duration
This behavioral parameter is also significantly affected by experimental group (see Table 1 ). MI pretreatment significantly decreased seizure duration as compared to SAL + PTZ and MAN + PTZ groups (t = 2.48, P = 0.015 and t = 1.99, P = 0.049, respectively, Fig. 1C ). SCI also significantly decreased the duration of seizures as compared to SAL + PTZ group (t = 2.00, P = 0.048). The difference between the MAN + PTZ and SCI + PTZ groups is not significant (P = 0.774). Other differences between the groups also have not been statistically significant.
Mortality rate
No significant differences have been observed between the groups for mortality rate by ANOVA analysis (see Table 1 ).
Discussion
The present study provides for the first time evidence of anticonvulsant action of SCI and expands our knowledge on anticonvulsant properties of MI. Both inositols significantly decrease the PTZ induced seizure scores, delay the latent period for the onset of seizures, and decrease the seizure duration. According to our pilot studies no anticonvulsive features are displayed by MI in the concentration range 5-15 mg/kg. Thus SCI is more effective at lower concentrations. Despite a six times higher concentration of MI compared to SCI in the present experiments, no significant differences were observed between MI + PTZ and SCI + PTZ groups. Inositol stereoisomers have different distribution of hydroxyl groups across the surfaces of the sugar ring and these differences could account for different effective concentrations of MI and SCI on PTZ induced seizures.
The effects of MI and SCI in our experiments are specific to MI and SCI as inositols. No statistically significant differences were found between two sham groups: saline and MAN (a polyol with a similar molecular weight to those of MI and SCI), and both groups were significantly different from the MI and SCI groups with respect to nearly all of the studied parameters.
The mechanism of anticonvulsant effects of inositols is not entirely clear. However, it has been widely recognized that depletion of levels of inositols has proconvulsant effect. Thus, proconvulsant effect of lithium has been attributed to its ability to block the action of inositol monophosphatase (IMPase). 12 Wellknown psychotrophic action of lithium in mania could be attributed to its block of IMPase, with concomitant decrease of free inositol (inositol depletion hypothesis[see 12]). Previous studies suggest that proconvulsant effects of lithium can be reversed by MI. [13] [14] [15] In all of these studies 10 mg of MI was administered intraventricularly (i.c.v.) or by peripheral administration of the corresponding dose (10 g/kg). According to these studies, to build the same levels of MI in human as in the rat, and achieve therapeutic effect, intake of 100 g inositol would be required daily. 13 This calculated dose is 15 times higher than doses used for the treatment of depression in humans by orally given inositol 16 or 300 times higher than the doses used in our present and previous studies in rats. 4, 5 These high doses of MI exceed the therapeutically safe concentrations and can be toxic. 15 All this questions the expediency of high doses MI treatment for possible therapeutic use in humans. However, the potential of SCI as a potential antiepileptic agent remains to be uncovered. According to a single report on antiepileptic features of SCI, high doses of SCI (10 mg) were administered i.c.v. and no anticonvulsant activity was observed in lithium-pilocarpine model of seizures. 17 The discrepancy between above-mentioned study and our own may be due to different models of epilepsy, doses or routes of administration of SCI. and Cl À takes place, which leads to inward flow of water and cellular swelling. 18, 19 Under such conditions various enzymes cannot function normally. 20 In compensation for this disturbed condition, neuronal and other cells accumulate high concentrations of small organic osmolytes, including MI, which do not perturb the functioning of the enzymes [21, 22, reviewed in 23] . This mechanism as well could be one of the factors in the anticonvulsant effects of MI. Some data, obtained from the experiments on pilocarpine-lithium models of seizures, also indicate that mechanism other than phosphoinositide depletion contributed to the MI response. 15 No data are available at present about the mechanism of action of SCI. In conclusion our present results indicate that MI and SCI in the range of physiological concentrations possess anticonvulsant properties on PTZ induced convulsions. Our previous data indicated anti-epiloptegenic and neuroprotective features of MI. 5, 24 Based on existing and present data we propose that, in The latency to the first observable seizure activity was measured for each animal and averaged in each treatment group. Data are provided as mean AE SEM. All data between the groups are compared by two-tailed ttest. (C) The duration of observable seizure activity was measured for each animal and mean values AE SEM are provided for each group. Groups were compared using a two-tailed ttest. addition to other functions, MI and SCI are endogenous anticonvulsants and that their actions should be explored in a broader range of epilepsy models.
